Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
July 28, 2014, 01:35:56 AM

Login with username, password and session length


Members
Stats
  • Total Posts: 632058
  • Total Topics: 47853
  • Online Today: 201
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online
Users: 5
Guests: 167
Total: 172

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: HIV Isolate From Kenya Provides Clues For Vaccine Design  (Read 2559 times)

0 Members and 1 Guest are viewing this topic.

Offline J220

  • Member
  • Posts: 587
HIV Isolate From Kenya Provides Clues For Vaccine Design
« on: January 09, 2008, 08:50:47 AM »
From http://www.sciencedaily.com/releases/2008/01/080102222848.htm ...any good news is good news...cheers, J.

HIV Isolate From Kenya Provides Clues For Vaccine Design

ScienceDaily (Jan. 6, 2008) Two simple changes in its outer envelope protein could render the AIDS virus vulnerable to attack by the immune system, according to research from Kenya and the Fred Hutchinson Cancer Research Center.
The results could provide important clues for designing an effective AIDS vaccine, which is badly needed to decrease the number of new HIV infections, now estimated at about 2.5 million per year worldwide.

Although most people infected with HIV produce antibodies against the virus within several weeks following infection, these antibodies rarely prevent the infection from progressing to symptomatic AIDS.

While studying a group of women at risk of HIV in Mombasa, Julie Overbaugh and colleagues noticed that one woman carried an AIDS virus that was easily inactivated by antibodies. They initially described this case in 2007 in the Journal AIDS.

Analyzing this woman's virus, they found that it contains mutations in four amino acids in the envelope protein, two of which, when introduced into unrelated strains of HIV in the laboratory, conferred sensitivity to inactivation by a number of antibodies produced in people infected with HIV.

The researchers propose that these mutations cause a change in the overall structure of the envelope protein that results in exposure to the immune system of regions that are normally hidden. If further research confirms this idea, vaccines containing envelope proteins that include these mutations might be able to stimulate an antibody response that would protect against infection with HIV.

Journal Citation: Blish CA, Nguyen MA, Overbaugh J (2008) Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41. PLoS Med 5(1): e9 http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050009

Adapted from materials provided by Public Library of Science.
"Hope is my philosophy
Just needs days in which to be
Love of Life means hope for me
Born on a New Day" - John David

Offline Merlin

  • Member
  • Posts: 642
  • As My WILL, So MOTE It Be !
Re: HIV Isolate From Kenya Provides Clues For Vaccine Design
« Reply #1 on: January 10, 2008, 03:49:24 PM »
Excellent news. Thanks for the post J22. Now Godspeed for a real vaccine this year!
I'll leave Hatred to those not strong enough to Love.

                            +++

Believe & The Power Of The Mind Transforms.
Make It Happen...

                            +++

I blame them for nothing.
I forgive them for everything.

---->> Mary J. Blige on dysfuctional parents

Offline bimazek

  • Member
  • Posts: 781
Re: HIV Isolate From Kenya Provides Clues For Vaccine Design
« Reply #2 on: January 10, 2008, 09:07:54 PM »
wow this is great
this is good news
kind of like the eigen vaccine but much simplier
keep watching dev. in this!

Offline J220

  • Member
  • Posts: 587
Re: HIV Isolate From Kenya Provides Clues For Vaccine Design
« Reply #3 on: January 10, 2008, 11:25:31 PM »
Indeed, I have no doubt that discoveries like this one, or one of the many other important ones made in the last year or two, will lead to a cure, mark my words.
"Hope is my philosophy
Just needs days in which to be
Love of Life means hope for me
Born on a New Day" - John David

Offline Sherbert

  • Member
  • Posts: 14
Re: HIV Isolate From Kenya Provides Clues For Vaccine Design
« Reply #4 on: January 14, 2008, 08:22:59 AM »
MERLIN:

I seen a post that you posted a little bit ago about ur lymphnodes and all..and I was just wondering if you had ever found out anything more about it or if you had gotten that massage done and if it helped?

Thanks

Sherbert :)

Offline mark86

  • Member
  • Posts: 33
Re: HIV Isolate From Kenya Provides Clues For Vaccine Design
« Reply #5 on: January 14, 2008, 12:21:46 PM »
Hi,

This may not be for this forum so i apologise if its in the wrong place but....

On a reply above, it states that...

Although most people infected with HIV produce antibodies against the virus within several weeks following infection, these antibodies rarely prevent the infection from progressing to symptomatic AIDS.

which is true... so what is going on in the intervening years between initial infection and AIDS..Isn't the immune system somehow containing the virus...i.e.killing some of it and keeping it in check until it finaly fails and cant do it anymore ?? Are Antibodies actually killing HIV during the Asymptomatic phase

am confused!!!!

Mark86

Offline redhotmuslbear

  • Member
  • Posts: 605
  • A genuine certified freak of nature, and a hot one
Re: HIV Isolate From Kenya Provides Clues For Vaccine Design
« Reply #6 on: January 14, 2008, 01:01:10 PM »
Are Antibodies actually killing HIV during the Asymptomatic phase

No, antibodies just "mark" HIV virions are invaders to be destroyed, but the suppressor and killer cell responses in most people doesn't catch up with the tagged HIV particles which other HIV particles burrow into CD4s to replicate.  Take a look at this slightly long discourse on HIV disease progression:  http://www.niaid.nih.gov/factsheets/howhiv.htm

I find it difficult to boil down to a Road Runner and Wile E Coyote analogy without med speak.

Cheers,
David
"The real problem is not whether machines think but whether men do." - BF Skinner
12-31-09   222wks VL  2430 CD4 690 (37%)
09-30-09   208wks VL  2050  CD4 925 (42%)
06-25-08   143wks VL  1359  CD4 668 (32%)  CD8 885
02-11-08   123wks off meds:  VL 1364 CD4 892(40%/0.99 ratio)
10-19-07   112wks off meds:   VL 292  CD4 857(37%/0.85 ratio)

One copy of delta-32 for f*****d up CCR5 receptors, and an HLA B44+ allele for "CD8-mediated immunity"... beteer than winning Powerball, almost!

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.